| MR编号 | NL/H/5646/001 |
|---|
| 药品名称 | Fluticasonfuroaat Teva 27,5 microgram/dosis, neusspray suspensie |
|---|
| 活性成分 | - Fluticasone furoate 27.5 µg/dose
|
|---|
| 剂型 | Nasal spray, suspension |
|---|
| 上市许可持有人 | Teva B.V.
Swensweg 5
2031 GA
Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Fluticasonfuroaat Teva 27,5 microgram/dosis, neusspray suspensie |
|---|
| 互认成员国 - 产品名称 | - Ireland (IE)
- France (FR)
- Portugal (PT)
- Finland (FI)
- Poland (PL)
Fluticasone furoate Teva - Latvia (LV)
- Estonia (EE)
- Czechia (CZ)
Fluticasone Teva - Denmark (DK)
Fluticasonfuroat Teva - Iceland (IS)
|
|---|
| 许可日期 | 2024/04/02 |
|---|
| 最近更新日期 | 2024/11/18 |
|---|
| 药物ATC编码 | - R01AD12 fluticasone furoate
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|